Building the Case for Dedicated 340B Program Management


Finance guys like myself often have the reputation of being unwilling to spend money. However, we can always be convinced to invest in activities with a high likelihood of return.

The financial pressures of the last year have underscored the importance of the 340B program and its impact on hospital finances. Against the backdrop of cost-cutting measures across the organization, it may seem counterintuitive to

Read More »

Thriving with HIV: How a Compassionate Pharmacy Technician Made All the Difference

SPONSORED CONTENT by Tyler Curry-McGrath, Avita Pharmacy

A patient newly diagnosed with HIV can often feel as if the cards are stacked against them before they even begin. Overcoming the fear and stigma of telling loved ones, finding the right doctor, navigating the insurance process, starting and staying in care—the journey ahead can seem like an impossible one. Even the smallest obstacles along the way can lead to

Read More »

Evolving Payor Strategies to Control Spending on Specialty Medications


The challenges that ‘white bagging’ poses for patients and providers are gaining attention as more health plans mandate these policies. ‘White bagging’ disrupts traditional ‘buy-and-bill’ practices for provider-administered drugs, creating patient safety concerns, operational problems, and financial challenges for covered entities.

Impact of ‘White Bagging’ Policies on Covered Entities

In the traditional ‘buy-and-bill’ model, covered entities maintain control of the

Read More »

How I Found My Mission


Over the course of my professional career which (at risk of dating myself) has spanned well over 30 years working exclusively in the healthcare field, I have lost count of how many times I have heard the phrase “America has the best healthcare in the world!” As a proud American, I would smile, nod my head to show agreement, and allow the comfort

Read More »

HRSA’s Order for 340B is a Win for Rural Accountable Care

SPONSORED CONTENT by Dr. LeeAnn Scheer, Caravan Health

Safety net facilities are celebrating the May 17 HRSA letters to six drug manufacturers affirming they must provide drugs to covered entities through their contract pharmacies at the 340B ceiling price. This decision will help these facilities, many of them rural, stretch this federal program to improve their financial sustainability and continue to provide excellent care in

Read More »

“Need to Know” – Visante’s Series of Key Takeaways for HRSA Grantees

SPONSORED CONTENT by Kristin Fox-Smith and William Wood, Visante

Those of us actively engaged in the 340B Program are well aware of the scores of issues faced by participating hospitals and it’s not surprising since they account for an exceptionally large percentage of all HRSA audits. But, what about other types of Covered Entities (CEs), such as the Specialty Clinics and Grantees?

Read More »

Tips & Tricks for Growing Your 340B Program

SPONSORED CONTENT by Lindsay Bennett, COO, Ravin Consultants

Many organizations take a siloed approach to 340B. If you’re treating your 340B program as strictly a pharmacy program, you’re probably missing out on savings. The reality is that 340B performance is inextricably linked to other areas of operations. Operational workflows, financial reporting, and human resources procedures can profoundly impact 340B savings. Ravin

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report

Site Footer